Literature DB >> 3493033

Extracellular ATP increases cytosolic free calcium in thymocytes and initiates the blastogenesis of the phorbol 12-myristate 13-acetate-treated medullary population.

C el-Moatassim, J Dornand, J C Mani.   

Abstract

Exogeneous nucleotides or nucleosides may influence lymphocyte functions such as proliferation and cytotoxicity. We report that ATP, and to a lesser extent ADP, at concentrations as low as 0.3 mM, are highly mitogenic for medullary mature thymocytes, when added in combination with phorbol myristate acetate (PMA), which is only weakly mitogenic by itself. Under the same conditions, the other nucleotides (AMP; GTP, ITP, 2'd-deoxyATP), the non-hydrolysable ATP analogs (p[NH]ppA, pp[CH2]pA) and adenosine are unable to trigger thymocyte blastogenesis. p[NH]ppA, a potent inhibitor of ATP hydrolysis, potentiates the ATP mitogenic effect. In contrast, T-cell-enriched splenocytes do not proliferate in response to ATP + PMA. These data and measurements of interleukin 2 synthesis suggest that ATP may efficiently deliver in thymocytes the calcium signal necessary for the initiation of blastogenesis (in medullary cells). Indeed, among all nucleotides tested, only ATP or ADP were able to increase the intracellular free calcium level in thymocytes, but not in splenocytes. Our results led us to suggest that thymocytes express on their surface receptors specific for ATP, which might be P2 type nucleotide receptors and could be involved in the lymphocyte response through the regulation of intracellular free calcium levels.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3493033     DOI: 10.1016/0167-4889(87)90110-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

1.  Extracellular ATP stimulates three different receptor-signal transduction systems in FRTL-5 thyroid cells. Activation of phospholipase C, and inhibition and activation of adenylate cyclase.

Authors:  K Sato; F Okajima; Y Kondo
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

Review 2.  Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses.

Authors:  Fenila Jacob; Claudina Pérez Novo; Claus Bachert; Koen Van Crombruggen
Journal:  Purinergic Signal       Date:  2013-02-13       Impact factor: 3.765

3.  P2-, but not P1-purinoceptors mediate formation of 1, 4, 5-inositol trisphosphate and its metabolites via a pertussis toxin-insensitive pathway in the rat renal cortex.

Authors:  C Nanoff; M Freissmuth; E Tuisl; W Schütz
Journal:  Br J Pharmacol       Date:  1990-05       Impact factor: 8.739

Review 4.  Extracellular adenine compounds, red blood cells and haemostasis: facts and hypotheses.

Authors:  J Lüthje
Journal:  Blut       Date:  1989-10

5.  LPS-stimulated bovine aortic endothelial cells produce IL-1 and IL-6 like activities.

Authors:  G Modat; J Dornand; N Bernad; D Junquero; A Mary; A Muller; C Bonne
Journal:  Agents Actions       Date:  1990-06

6.  Activation of early events of the mitogenic response by a P2Y purinoceptor with covalently bound 3'-O-(4-benzoyl)-benzoyladenosine 5'-triphosphate.

Authors:  F A Gonzalez; D J Wang; N N Huang; L A Heppel
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

7.  Inhibition of murine T-cell responses by anti-oxidants: the targets of lipo-oxygenase pathway inhibitors.

Authors:  J Dornand; M Gerber
Journal:  Immunology       Date:  1989-11       Impact factor: 7.397

8.  P2X(7): a growth-promoting receptor-implications for cancer.

Authors:  Francesco Di Virgilio; Davide Ferrari; Elena Adinolfi
Journal:  Purinergic Signal       Date:  2009-03-04       Impact factor: 3.765

9.  Mobilization of intracellular Ca2+ by adenine nucleotides in human T-leukaemia cells: evidence for ADP-specific and P2y-purinergic receptors.

Authors:  M Biffen; D R Alexander
Journal:  Biochem J       Date:  1994-12-15       Impact factor: 3.857

Review 10.  Purinergic signalling in endocrine organs.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.